Stem cell therapy offers a promising avenue for diabetes treatment by potentially regenerating insulin-producing beta cells. Unlike traditional insulin therapy, regenerative medicine aims to restore natural glucose regulation, reducing dependency on injections. Research explores embryonic, adult, and induced pluripotent stem cells to develop long-term solutions, bringing hope for a future where diabetes management moves beyond insulin reliance.